Synthace has announced a collaboration with Charles River Laboratories International, Inc. to provide Charles River’s clients with access to Synthace’s software for developing, automating, and transferring assays. This partnership aims to address the reproducibility crisis in biological research, which costs an estimated $100 billion annually, by offering a more robust, faster, and cost-effective method for assay development. The collaboration leverages Design of Experiments (DoE), automation, and software to improve experimental rigor and achieve seamless transfer between laboratories.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Synthace collaborates with Charles River to offer the global pharma industry more robust, faster and cost-effective assays
Synthace has announced a collaboration with Charles River Laboratories International, Inc. to provide Charles River’s clients with access to Synthace’s software for developing, automating, and transferring assays. This partnership aims to address the reproducibility crisis in biological research, which costs an estimated $100 billion annually, by offering a more robust, faster, and cost-effective method for assay development. The collaboration leverages Design of Experiments (DoE), automation, and software to improve experimental rigor and achieve seamless transfer between laboratories.